XML 80 R35.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Significant Accounting Policies (Details) - V C N - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Oct. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Mar. 10, 2022
Summary of Significant Accounting Policies          
Additional consideration related to the achievement of certain milestones     $ 70,200,000    
Amount to be paid due to approval   $ 3,000,000.0      
Payment made after clinical trial $ 3,250,000        
Fair value of contingent consideration   $ 10,200,000 6,300,000 $ 10,200,000 $ 11,093,000
Fair value measurement, transfer in to level3     0 $ 0  
Exception of reclassification     $ 3,250,000